Populationpharmacokinetic/pharmacodynamic modeling of a new recombinant human factor VIIA (LR769) to derive the dose to be studied in phase 3

J. Frieling, J. Stevens, J. Reijers, M. Moerland, J. Burggraaf, K. van Leuven, C. Kluft, J-F Schved

Research output: Contribution to journalMeeting AbstractAcademic

Original languageEnglish
Pages (from-to)966-966
Number of pages1
JournalJournal of Thrombosis and Haemostasis
Volume13
Publication statusPublished - Jun-2015

Cite this